miRNA-3157

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamemiRNA-3157
Drug Alias NamemiRNA-based therapeutics (InteRNA Technologies)miR-3157
ClassificationSmall molecules > LipidSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInterna Technologies Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInterna Technologies Bv
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A